BlackRock’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.9M | Buy |
6,781,046
+296,038
| +5% | +$3.88M | ﹤0.01% | 2099 |
|
|
2025
Q1 | $143M | Buy |
6,485,008
+5,993
| +0.1% | +$132K | ﹤0.01% | 1774 |
|
|
2024
Q4 | $173M | Buy |
6,479,015
+85,448
| +1% | +$2.28M | ﹤0.01% | 1742 |
|
|
2024
Q3 | $171M | Buy |
6,393,567
+377,856
| +6% | +$10.1M | ﹤0.01% | 1743 |
|
|
2024
Q2 | $108M | Buy |
6,015,711
+848,705
| +16% | +$15.3M | ﹤0.01% | 1958 |
|
|
2024
Q1 | $94.2M | Buy |
5,167,006
+1,859,896
| +56% | +$33.9M | ﹤0.01% | 2057 |
|
|
2023
Q4 | $36.2M | Buy |
3,307,110
+321,266
| +11% | +$3.51M | ﹤0.01% | 2630 |
|
|
2023
Q3 | $17.1M | Sell |
2,985,844
-148,324
| -5% | -$850K | ﹤0.01% | 2981 |
|
|
2023
Q2 | $24.3M | Buy |
3,134,168
+263,161
| +9% | +$2.04M | ﹤0.01% | 2853 |
|
|
2023
Q1 | $19.1M | Sell |
2,871,007
-2,617
| -0.1% | -$17.5K | ﹤0.01% | 2941 |
|
|
2022
Q4 | $25.7M | Buy |
2,873,624
+758,154
| +36% | +$6.78M | ﹤0.01% | 2848 |
|
|
2022
Q3 | $20.8M | Buy |
2,115,470
+61,902
| +3% | +$609K | ﹤0.01% | 2962 |
|
|
2022
Q2 | $16.3M | Sell |
2,053,568
-1,592
| -0.1% | -$12.7K | ﹤0.01% | 3129 |
|
|
2022
Q1 | $19.9M | Buy |
2,055,160
+7,557
| +0.4% | +$73.3K | ﹤0.01% | 3105 |
|
|
2021
Q4 | $31.3M | Buy |
2,047,603
+1,467,371
| +253% | +$22.4M | ﹤0.01% | 2945 |
|
|
2021
Q3 | $9.63M | Buy |
580,232
+12,774
| +2% | +$212K | ﹤0.01% | 3636 |
|
|
2021
Q2 | $12.1M | Buy |
567,458
+511,973
| +923% | +$10.9M | ﹤0.01% | 3517 |
|
|
2021
Q1 | $1.8M | Buy |
+55,485
| New | +$1.8M | ﹤0.01% | 4251 |
|